Showing 1–6 of 6 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Luis M Rodríguez-Martínez, Jose L Chavelas-Reyes, Carlo F Medina-Ramírez, Eli Fuentes-Chávez, Zurisaday S Muñoz-Troncoso, et al.
…f drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotypin…
Agata Maciejak-Jastrzębska, Grażyna Sygitowicz, Sylwia Brzezińska, Kinga Bielska, Ewa Augustynowicz-Kopeć
…logical and structural characteristics of mycobacteria; the epidemiology of the disease; and the role of the main diagnostic methods; with a particular focus on molecular methods and MALDI-TOF MS. This paper highlights their advantages and limitations and discusses their implicat…
Hemali Savla, Bhushan S. Bhale, Nisha Sharma, Pradnya R. Petkar
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a major public health problem affecting millions of people worldwide. The emergence of multidrug-resistant (MDR) and extremely drug-resistant (XDR) strains of Mtb has further increased the disease-related mortality…
Terry E. Robinson, Jane Scullion
…facts about tuberculosis (TB), then goes on to describe the epidemiology and pathophysiology of the disease. Risk factors, and signs and symptoms, and investigations are all covered. The treatment phase and standard drug therapies are shown, and directly observed therapy for the …
Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, Alexandra Aubry, Francis Drobniewski, et al.
…apacity. By aligning diagnostic practices with the regional epidemiology and laboratory infrastructure, this stepwise, resource-sensitive approach aims to strengthen TB control, improve treatment outcomes, and guide public health action in the EU/EEA.
Omid Nikjeh, Seyedehparmis Rejali, Kayvan Sasaninia, Vishwanath Venketaraman
…unosuppression. This review synthesizes current evidence on epidemiology, clinical features, and management challenges of HIV-mycobacterial co-infections. We discuss drug-susceptible and drug-resistant TB therapies, drug-drug interactions with antiretroviral therapy (ART), and th…